SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 197 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $105,000 | -98.8% | 11,127 | -99.2% | 0.00% | -98.9% |
| Q1 2020 | $8,683,000 | +215.1% | 1,363,039 | +313.9% | 0.09% | +357.9% |
| Q4 2019 | $2,756,000 | +840.6% | 329,326 | +917.8% | 0.02% | +850.0% |
| Q3 2019 | $293,000 | -96.4% | 32,358 | -95.5% | 0.00% | -97.6% |
| Q4 2018 | $8,181,000 | +1678.5% | 712,657 | +2526.2% | 0.08% | +4100.0% |
| Q3 2018 | $460,000 | -9.3% | 27,136 | -51.8% | 0.00% | -90.9% |
| Q2 2017 | $507,000 | – | 56,314 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIC CAPITAL INC | 875,284 | $2,670,000 | 1.34% |
| NEXTHERA CAPITAL LP | 503,000 | $1,534,000 | 0.90% |
| Opaleye Management Inc. | 400,000 | $1,220,000 | 0.72% |
| WASATCH ADVISORS LP | 7,256,260 | $22,132,000 | 0.33% |
| Cormorant Asset Management, LP | 650,000 | $1,983,000 | 0.27% |
| Sicart Associates LLC | 101,950 | $311,000 | 0.22% |
| Baker Brothers Advisors | 4,055,876 | $12,370,000 | 0.12% |
| Leisure Capital Management | 43,008 | $131,000 | 0.12% |
| Piermont Capital Management Inc. | 165,569 | $505,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 837,963 | $2,556,000 | 0.10% |